Literature DB >> 21704321

The prognostic significance of electrocardiographic changes in Chagas disease.

Bruno Ramos Nascimento1, Christiano Gonçalves Araújo, Manoel Otávio Costa Rocha, José Darlan Pinheiro Domingues, Aline Braga Rodrigues, Márcio Vinicius Lins Barros, Antonio Luiz Pinho Ribeiro.   

Abstract

INTRODUCTION: The meaning of electrocardiographic changes appearing during the clinical follow-up of Chagas disease (ChD) is unknown. In this study, a patient cohort with ChD was followed to describe the electrocardiographic changes that may make it possible to identify patients whose left ventricular function has deteriorated.
METHODS: The study sample consisted of a prospective cohort followed since 1998 to 1999, involving 220 patients aged 15 to 55 years, 30 controls, and 190 with ChD, without other comorbidities. The group was reexamined between 2004 and 2006, and new electrocardiograms were obtained for 153 patients, 25 (83%) of 30 in the control group and 128 (72%) of 177 in the ChD group. Electrocardiographic variables associated with a significant decrease in ejection fraction (5% or more) were identified.
RESULTS: A significant decrease in ejection fraction was observed in 21 patients in the ChD group (18.7%) but in none of the non-ChD group (P = .024). Only the presence of a new electrocardiographic abnormality and an increase in QRS duration correlated with a decrease in an ejection fraction of 5% or more. QRS duration was correlated with both an increase in left ventricle diastolic diameter and a deterioration in the ejection fraction (r(s) = 0.225, P = .017, and r(s) = -0.300, P < .001). A QRS increase of 5 milliseconds had 77.8% sensitivity and 62.2% specificity for identifying patients with significant decrease in ejection fraction.
CONCLUSION: The increase in the duration of the QRS complex and the appearance of new electrocardiographic alterations may help in identifying patients with a significant decrease (of 5% or more) in left ventricle ejection fraction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21704321     DOI: 10.1016/j.jelectrocard.2011.04.011

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  10 in total

1.  Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection.

Authors:  Maria A P Martins; Daniel D Ribeiro; Vandack A Nobre; Fabiana R Pereira; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2012-09-28       Impact factor: 2.953

2.  Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.

Authors:  Antonio B Fernandez; Maria Carmo P Nunes; Eva H Clark; Aaron Samuels; Silvio Menacho; Jesus Gomez; Ricardo W Bozo Gutierrez; Thomas C Crawford; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

3.  Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy.

Authors:  Sithu Win; Monica Miranda-Schaeubinger; Ronald Gustavo Durán Saucedo; Paula Carballo Jimenez; Jorge Flores; Brandon Mercado-Saavedra; Lola Camila Telleria; Anne Raafs; Manuela Verastegui; Caryn Bern; Freddy Tinajeros; Stephane Heymans; Rachel Marcus; Robert H Gilman; Monica Mukherjee
Journal:  Int J Cardiol Heart Vasc       Date:  2022-05-23

Review 4.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

5.  Prevalence of Chagas Disease in a U.S. Population of Latin American Immigrants with Conduction Abnormalities on Electrocardiogram.

Authors:  Mahmoud I Traina; Salvador Hernandez; Daniel R Sanchez; Jalal Dufani; Mohsin Salih; Adieb M Abuhamidah; Wilman Olmedo; Jason S Bradfield; Colin J Forsyth; Sheba K Meymandi
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

6.  Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy.

Authors:  David Santacruz; Fernando Rosas; Carina Abigail Hardy; Diego Ospina; Andrea Nathalie Rosas; Juan Manuel Camargo; Juan José Bermúdez; Juan Felipe Betancourt; Víctor Manuel Velasco; Mario D González
Journal:  Heart Rhythm O2       Date:  2021-12-17

7.  Contextual influence on poor self-rated health in patients with Chagas disease: multilevel study.

Authors:  Ariela Mota Ferreira; Ester Cerdeira Sabino; Léa Campos de Oliveira-da Silva; Cláudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Antonio Luiz Pinho Ribeiro; Renata Fiúza Damasceno; Sâmara Fernandes Leite; Thallyta Maria Vieira; Maria do Carmo Pereira Nunes; Desirée Sant' Ana Haikal
Journal:  Cien Saude Colet       Date:  2022-02-26

8.  Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.

Authors:  Antonio L Ribeiro; Ester C Sabino; Milena S Marcolino; Vera M C Salemi; Barbara M Ianni; Fábio Fernandes; Luciano Nastari; André Antunes; Márcia Menezes; Cláudia Di Lorenzo Oliveira; Vandana Sachdev; Danielle M Carrick; Michael P Busch; Eduard L Murphy
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

9.  Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment.

Authors:  Jonathan Soverow; Salvador Hernandez; Daniel Sanchez; Colin Forsyth; Carmen A Flores; Gracia Viana; Sheba Meymandi
Journal:  Open Forum Infect Dis       Date:  2019-01-19       Impact factor: 3.835

10.  Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients-The SaMi-Trop cohort.

Authors:  Bruno Oliveira de Figueiredo Brito; Zachi I Attia; Larissa Natany A Martins; Pablo Perel; Maria Carmo P Nunes; Ester Cerdeira Sabino; Clareci Silva Cardoso; Ariela Mota Ferreira; Paulo R Gomes; Antonio Luiz Pinho Ribeiro; Francisco Lopez-Jimenez
Journal:  PLoS Negl Trop Dis       Date:  2021-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.